Intrinsic Value of S&P & Nasdaq Contact Us

Dyadic International, Inc. DYAI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+244.8%

Dyadic International, Inc. (DYAI) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.

The consensus price target is $3.00, representing an upside of 244.8% from the current price $0.87.

Analysts estimate Earnings Per Share (EPS) of $-0.18 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.20 vs est $-0.18 (missed -11.1%). 2025: actual $-0.23 vs est $-0.23 (missed -2.2%). Analyst accuracy: 94%.

DYAI Stock — 12-Month Price Forecast

$3.00
▲ +244.83% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for Dyadic International, Inc., the price target is $3.00.
The average price target represents a +244.83% change from the last price of $0.87.

DYAI Analyst Ratings

Buy
2
Ratings
1 Buy
1 Hold
Based on 2 analysts giving stock ratings to Dyadic International, Inc. in the past 3 months
Rating breakdown
Buy
1 50%
Hold
1 50%
50%
Buy
1 analysts
50%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — DYAI

94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.20 vs Est –$0.18 ▼ 10.0% off
2025 Actual –$0.23 vs Est –$0.23 ▼ 2.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — DYAI

76%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024 Actual $0.003B vs Est $0.004B ▼ 23.0% off
2025 Actual $0.003B vs Est $0.004B ▼ 24.8% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message